The FDA accepted the biologics license applications (BLA) for AVT05, Alvotech’s and Teva Pharmaceuticals’ proposed biosimilar to golimumab (Simponi and Simponi Aria), which treats inflammatory ...

The FDA is set to review the Biologics License Applications (BLAs) for Alvotech’s AVT05, a proposed biosimilar to Simponi and Simponi Aria, branded forms of golimumab, which is a medication prescribed ...

The U.S. Food and Drug Administration (FDA) has accepted for review Biologics License Applications (BLA) for AVT05, Alvotech’s proposed biosimilar to Simponi and Simponi Aria (golimumab), which are ...

Experts say the kuranui, otherwise known as moa, played a vital part in sustaining rākau Māori, crucial to the wellbeing of the taiao and the Māori language. The kuranui, otherwise known as moa ...

This marks the first U.S. BLA acceptance for a golimumab biosimilar, an anti-TNF therapy for rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. The FDA review is expected to ...

A SEVENTEEN pop-up store has officiall opened at the Mall of Asia on Wednesday. But it's not just any SEVENTEEN pop-up store, it's an “Artist-Made Collection by SEVENTEEN” pop-up store. Located at the ...

This summer we’re revisiting some of the most-listened to podcasts from across the NZ Herald network in 2024. Singer, songwriter and broadcaster Anika Moa describes her ADHD as ‘15,000 voices ...

Speaking of major milestones, Disney’s Moana 2 is now on course to join the billion-dollar club worldwide, with $960.5M through Sunday; Universal/Focus’ Nosferatu topped $100M global this ...

Here’s how the weekend went globally and overseas. Lots to celebrate: Disney’s Mufasa: The Lion King is now the No. 9 global release of 2024 with $539.7M, including $350.9M from the ...